Interleukin-6 prevents NMDA-induced neuronal death via Gp130 signaling-dependent IP3R inhibition

Ao-Wang Qiu1, Qin Yang2, Song-Tao Yuan2

  • 1Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu Province 210029, China. qinghuailiu@163.com.

Abstract

Insights

Interleukin-6 (IL-6) protects neurons from N-methyl-D-aspartate (NMDA) induced cell death by inhibiting inositol 1,4,5-trisphosphate receptors (IP3R). This neuroprotection relies on gp130 signaling, not ryanodine receptors (RyR).

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Neuronal apoptosis and necrosis are critical in neurodegenerative diseases.
  • Interleukin-6 (IL-6) is a cytokine with known neuroprotective roles.
  • Inositol 1,4,5-trisphosphate receptors (IP3R) and ryanodine receptors (RyR) are key regulators of intracellular calcium release.

Purpose of the Study:

  • To investigate the roles of IP3R and RyR in IL-6 mediated neuroprotection against N-methyl-D-aspartate (NMDA) induced cell death.
  • To elucidate the signaling pathways involved in IL-6's protective effects.

Main Methods:

  • Primary cultures of cerebellar granule neurons (CGNs) were treated with IL-6 and then stimulated with NMDA.
  • IP3R and RyR were antagonized using 2-aminoethoxydiphenyl borate (2-APB) and dantrolene (DAN), respectively.
  • Neuronal death was assessed using TUNEL, caspase-3 activity, and annexin V-FITC/PI staining.
  • Expression of IP3R1 and RyR2 was analyzed via Western blot and real-time PCR.

Main Results:

  • IL-6 significantly reduced NMDA-induced neuronal apoptosis and necrosis.
  • The neuroprotective effects of IL-6 were more pronounced with IP3R antagonism (2-APB) than RyR antagonism (DAN).
  • IL-6 downregulated IP3R1 expression but did not affect RyR2 expression.
  • Anti-gp130 monoclonal antibody blocked all IL-6 mediated neuroprotective effects.

Conclusions:

  • IL-6 confers neuroprotection against NMDA-induced cell death by inhibiting IP3R activity and expression, not RyR.
  • gp130 signaling downstream of the IL-6 receptor mediates this neuroprotective effect.
  • These findings highlight IP3R as a therapeutic target for neuroprotection.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K